<DOC>
	<DOCNO>NCT02356614</DOCNO>
	<brief_summary>This post-approval , multicenter , prospective , non-randomized , open-label , clinical study evaluate safety effectiveness LAP-BAND® AP System low obese population ( BMI ≥ 30 kg/m2 &lt; 40 kg/m2 ) one obesity-related comorbidity 10 year implantation .</brief_summary>
	<brief_title>A Post-approval LAP-BAND® Lower Body Mass Index ( LBMI ) Study</brief_title>
	<detailed_description>FDA post-approval study design collect prospective data real-world set evaluate long-term safety effectiveness LAP BAND® System patient BMI ≥ 30 kg/m2 &lt; 40 kg/m2 one comorbid condition . The Apollo-001 Study prospective , 10 year , multicenter study patient decide undergo implantation LAP-BAND AP® system . Outcomes include device explants , change weight , comorbid condition status , device- procedure-related AEs , reoperations .</detailed_description>
	<mesh_term>Overweight</mesh_term>
	<criteria>1 . LAPBAND® System place facility United States 2 . BMI ≥ 30 kg/m2 &lt; 40 kg/m2 prior LAPBAND® placement 3 . Presence 1 obesityrelated comorbidities prior LAPBAND® placement 4 . Aged 18 old 1 . Prior bariatric surgery . 2 . Participating another ongoing clinical study concomitant diagnostic therapeutic intervention would reasonably expect alter pattern care , use medication outcome study . 3 . Vulnerable patient unable exercise free inform consent . 4 . Inability complete questionnaire . 5 . Patients addict alcohol and/or drug .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Lap Band</keyword>
</DOC>